help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 31, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0437
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/8/4503    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerber, M.
Right arrow Articles by Kratzsch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerber, M.
Right arrow Articles by Kratzsch, J.

Submitted on February 28, 2005
Accepted on May 24, 2005

Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance

M. Gerber, A. Boettner, B. Seidel, A. Lammert, J. Bär, E. Schuster, J. Thiery, W. Kiess, and J. Kratzsch*

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Paul-List-Str.13-15, 04103 Leipzig; Hospital for Children and Adolescents, Faculty of Medicine, University of Leipzig, Oststr. 21-25, D 04317 Leipzig, Germany; Institute of Biochemistry, Faculty of Medicine, University of Leipzig, Liebigstr. 16, D 04103 Leipzig, Germany; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Haertelstr. 16/18, D 04107 Leipzig, Germany

* To whom correspondence should be addressed. E-mail: kraj{at}medizin.uni-leipzig.de.

Objective: It was hypothesized that resistin links obesity with diabetes, but this has not been studied in children and adolescents to date. Patients: We determined serum resistin levels of 135 obese (BMI 32.0 ± 6.2, age 12.6 ± 3.4) and 201 lean children (BMI 18.7 ± 2.4, age 12.5 ± 2.5) by a newly developed and extensively evaluated in-house immunoassay. These results were controlled for their association with markers of puberty, obesity and insulin sensitivity.

Results: The analytical evaluation of our assay revealed different resistin isoforms with major peaks of higher than 660 kDa and 55 kDa in the size exclusion chromatography. Using this assay system we found no difference in the resistin levels of obese compared with lean subjects (P = 0.48). However, resistin was significantly higher in girls than in boys (6.74 ± 2.42 vs. 5.79 ± 2.45; P < 0.001). Interestingly, in both, obese and lean children, resistin correlated with age (P < 0.01), Tanner stage, testosterone and estradiol levels (P < 0.05). In contrast, no significant correlation was found with parameters of insulin resistance such as HOMA, ISI or insulin, proinsulin and glucose concentrations in obese subjects.

Conclusions: Resistin appears to be not the main link between obesity and insulin resistance in children and adolescents but due to its association with Tanner stage it may be related to the maturation of children during pubertal development. Additionally, we have demonstrated the presence of different molecular isoforms of resistin in human blood and this may raise problems in comparing data from diverse assay systems.


Key words: Resistin • puberty • obesity • insulin resistance • children




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
R. S. Ahima and M. A. Lazar
Adipokines and the Peripheral and Neural Control of Energy Balance
Mol. Endocrinol., May 1, 2008; 22(5): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ellington, A. R. Malik, G. G. Klee, S. T. Turner, A. D. Rule, T. H. Mosley Jr, and I. J. Kullo
Association of Plasma Resistin With Glomerular Filtration Rate and Albuminuria in Hypertensive Adults
Hypertension, October 1, 2007; 50(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Beauloye, F. Zech, H. Tran Thi Mong, P. Clapuyt, M. Maes, and S. M. Brichard
Determinants of Early Atherosclerosis in Obese Children and Adolescents
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3025 - 3032.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Osawa, Y. Tabara, R. Kawamoto, J. Ohashi, M. Ochi, H. Onuma, W. Nishida, K. Yamada, J. Nakura, K. Kohara, et al.
Plasma Resistin, Associated With Single Nucleotide Polymorphism -420, Is Correlated With Insulin Resistance, Lower HDL Cholesterol, and High-Sensitivity C-Reactive Protein in the Japanese General Population
Diabetes Care, June 1, 2007; 30(6): 1501 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Qi, Z. Nie, Y.-S. Lee, N. S. Singhal, P. E. Scherer, M. A. Lazar, and R. S. Ahima
Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency
Diabetes, November 1, 2006; 55(11): 3083 - 3090.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G. A Martos-Moreno, V. Barrios, and J. Argente
Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids
Eur. J. Endocrinol., September 1, 2006; 155(3): 429 - 434.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. Haluzik, Z. Lacinova, M. Dolinkova, D. Haluzikova, D. Housa, A. Horinek, Z. Vernerova, T. Kumstyrova, and M. Haluzik
Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-{alpha} Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels
Endocrinology, September 1, 2006; 147(9): 4517 - 4524.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K.-D. Nusken, J. Kratzsch, V. Wienholz, W. Stohr, W. Rascher, and J. Dotsch
Circulating resistin concentrations in children depend on renal function
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 107 - 112.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society